Recombinant Mycoplasma pneumoniae Uncharacterized protein MG246 homolog (MPN_349)
Product Specs
Q&A
What bioinformatic approaches are most effective for initial characterization of MPN_349?
For initial characterization of uncharacterized proteins like MPN_349, a comprehensive bioinformatic workflow is essential. Begin with physicochemical parameter prediction, domain and motif identification, and subcellular localization prediction using programs with receiver operating characteristics (ROC), which can achieve accuracy rates around 83.6% for various parameters .
A methodological approach includes:
-
Sequence analysis through BLASTp to identify potential homologs
-
Domain and motif analysis using databases like Pfam and InterPro
-
Secondary structure prediction
-
Function prediction based on structural homology
-
String analysis to reveal interacting partners with confidence scores >1
For MPN_349 specifically, comparing it with the characterized MPN490 (RecA homolog) may provide insights into potential DNA metabolism functions, given that both are proteins of interest in Mycoplasma pneumoniae .
What expression systems are recommended for producing recombinant MPN_349 protein?
When expressing recombinant proteins from Mycoplasma species, several expression systems can be considered, with yeast systems like Pichia pastoris showing particular promise for heterologous proteins .
The P. pastoris expression system offers several advantages:
-
Proper protein folding capabilities
-
High expression levels
-
Secretion of recombinant proteins
-
Suitability for producing biopharmaceuticals and industrial enzymes
A methodological approach for expression in P. pastoris includes:
-
Cloning of the recombinant cassette into a suitable expression vector
-
Transformation of foreign vector DNAs into yeast by electroporation
-
Optimization and large-scale expression of recombinant proteins
Table 1: Comparison of Expression Systems for Mycoplasma Proteins
| Expression System | Advantages | Limitations | Suitability for MPN_349 |
|---|---|---|---|
| E. coli | Rapid growth, high yields, simple genetics | Limited post-translational modifications | May form inclusion bodies due to membrane-associated domains |
| P. pastoris | Proper protein folding, secretion capability | Longer expression time | Recommended for structural studies |
| Mammalian cells | Native-like post-translational modifications | Expensive, lower yields | For specific functional studies |
| Cell-free systems | Avoids toxicity issues | Low yields | For preliminary functional assays |
How can researchers functionally annotate MPN_349?
Functional annotation of uncharacterized proteins like MPN_349 requires a systematic approach combining in silico prediction with experimental validation .
A comprehensive methodological workflow includes:
-
Physicochemical parameter prediction using tools like ProtParam
-
Domain and motif search using InterProScan
-
Pattern search in specialized databases
-
Subcellular localization prediction using algorithms specific for bacterial proteins
-
Structure prediction and modeling using homology-based approaches
Following computational prediction, experimental validation is essential:
-
Recombinant expression and purification
-
Biochemical assays based on predicted functions
-
Protein-protein interaction studies
-
Structural analysis using X-ray crystallography or NMR
This systematic approach has successfully assigned functions to numerous uncharacterized proteins, classifying them as enzymes, transporter proteins, membrane proteins, or binding proteins .
What is the relationship between MPN_349 and other characterized proteins in Mycoplasma pneumoniae?
Understanding the relationship between MPN_349 and other characterized proteins requires string analysis and comparative genomics approaches. For Mycoplasma pneumoniae proteins, string analysis can identify potential functional partners with high confidence scores .
The methodological approach involves:
-
Submitting the MPN_349 sequence to STRING database
-
Filtering interactions based on confidence scores (>1)
-
Analyzing predicted interactions based on:
Given that MPN490 in M. pneumoniae has been characterized as a RecA homolog involved in homologous recombination , examining potential interactions between MPN_349 and DNA metabolism proteins could reveal functional relationships. Sequence analysis may also reveal similarities to the M. genitalium MG339 gene product, which promotes recombination between homologous DNA substrates in an ATP-dependent manner .
How can researchers design experiments to determine if MPN_349 has recombinational activity?
If sequence analysis suggests MPN_349 may be involved in DNA metabolism, designing experiments to test for recombinational activity would follow the methodological approach used for other M. pneumoniae proteins:
-
Cloning and expression of recombinant MPN_349
-
Purification under native conditions
-
In vitro recombination assays using homologous DNA substrates
-
Analysis of ATP dependency
-
Assessment of Mg²⁺ and pH dependence
-
Testing the effect of single-stranded DNA binding protein on activity
Research on RecA homologs in M. pneumoniae has demonstrated that these proteins promote recombination between homologous DNA substrates in an ATP-dependent fashion. The recombinational activities were found to be Mg²⁺ and pH dependent and were strongly supported by the presence of single-stranded DNA binding protein .
Table 2: Experimental Design for Testing Recombinational Activity
| Parameter | Control Conditions | Test Conditions | Expected Outcome if Active |
|---|---|---|---|
| ATP dependency | No ATP | 1-5 mM ATP | Activity only with ATP present |
| Mg²⁺ dependency | No Mg²⁺ | 2-10 mM Mg²⁺ | Optimal activity at specific Mg²⁺ concentration |
| pH optimization | pH range 5.5-8.5 | pH increments of 0.5 | Bell-shaped activity curve |
| ssDNA binding protein | Without protein | With protein | Enhanced recombination activity |
What structural modeling approaches yield the most reliable predictions for MPN_349?
For structural modeling of uncharacterized proteins like MPN_349, homology-based approaches using Swiss-PDB and Phyre2 servers have proven effective, even with sequence identities ranging from 14% to 97% .
The methodological workflow includes:
-
Template identification through sequence similarity searches
-
Selection of templates with maximum sequence coverage
-
Model building using multiple algorithms
-
Model quality assessment using PROCHECK
-
Structural refinement for models with lower sequence identity
For challenging targets with low homology to known structures:
-
Ab initio modeling for smaller domains
-
Integration of experimental constraints where available
-
Fragment-based approaches for regions with poor template coverage
The reliability of structural models decreases with lower sequence identity to the template, but even low-identity models can provide valuable insights into potential functional regions and guide experimental design .
How can researchers effectively present complex data on MPN_349 characterization?
Presenting research data on uncharacterized proteins like MPN_349 requires adherence to scientific reporting standards that maximize clarity and impact. Follow the principle of "first general, then specific," beginning with basic characterization before proceeding to specific functional findings .
Key methodological considerations include:
-
Start with description of experimental approach and samples
-
Present key findings followed by relevant statistical analyses
-
Use past tense in describing results
-
Select the appropriate format (text, tables, or graphics) based on data type
For tables presenting protein characterization:
-
Keep titles brief but informative
-
Present similar data in columns for easier comparison
-
Use footnotes for marking statistical significance rather than separate columns for p-values
Table 3: Example Format for Presenting MPN_349 Characterization Data
| Parameter | Wild Type MPN_349 | Mutant MPN_349 | Statistical Significance |
|---|---|---|---|
| Molecular Weight (kDa) | 52.3 ± 0.2 | 48.7 ± 0.3 | * |
| Isoelectric Point | 6.8 ± 0.1 | 7.2 ± 0.1 | * |
| DNA Binding (Kd, nM) | 125.3 ± 12.7 | 347.8 ± 25.9 | ** |
| ATPase Activity (nmol/min/mg) | 22.6 ± 3.1 | 4.2 ± 0.8 | ** |
*p < 0.05, **p < 0.01
How can researchers differentiate between critical functional residues and non-essential regions in MPN_349?
Differentiating between critical functional residues and non-essential regions in uncharacterized proteins requires a multi-faceted approach combining computational prediction with experimental validation.
A comprehensive methodological workflow includes:
-
Conservation analysis across related Mycoplasma species
-
Consensus prediction using multiple independent tools
-
Correlation of predicted sites with structural features
-
Site-directed mutagenesis of candidate residues
When implementing this approach for MPN_349:
-
Align sequences from M. pneumoniae, M. genitalium, and other related species
-
Identify highly conserved residues, particularly those in predicted functional domains
-
Generate structural models to identify surface-exposed residues that might participate in interactions
-
Create alanine substitution mutants of candidate residues
-
Test the mutants for altered activity in functional assays
Table 4: Validation Framework for Predicted Functional Residues
| Validation Method | Approach | Strength of Evidence | Implementation for MPN_349 |
|---|---|---|---|
| Sequence conservation | Multiple sequence alignment | Strong for conserved residues | Compare across Mycoplasma species |
| Structural context | Surface accessibility analysis | Medium | Map conserved residues onto structural model |
| Domain prediction | Identify known functional motifs | Medium-High | Search for RecA-like motifs if applicable |
| Mutagenesis | Alanine scanning | Definitive | Target conserved, surface-exposed residues |
What is known about the potential role of MPN_349 in Mycoplasma pneumoniae pathogenicity?
Understanding the potential role of uncharacterized proteins in pathogenicity requires examining their similarity to known virulence factors and their potential interactions with host proteins.
For MPN_349, a methodological approach would include:
-
Homology detection with human proteins to identify potential molecular mimicry
-
Searching in DrugBank database for identification of similar druggable candidates
-
Analysis of expression patterns during infection
The potential role in pathogenicity can be evaluated by:
-
Generating gene knockout or knockdown strains
-
Comparing virulence between wild-type and mutant strains in cellular models
-
Analyzing bacterial adherence, invasion, and persistence
-
Measuring host immune responses to purified recombinant protein
While specific information about MPN_349's role in pathogenicity is limited, functional annotation studies of uncharacterized proteins have identified probable virulence factors that could be investigated further for potential drug-related studies .
